Manuscripts
Showing 1542 manuscripts.
Effect of pregnancy versus postpartum maternal isoniazid preventive therapy on infant growth in HIV-exposed uninfected infants: a post-hoc analysis of the TB APPRISE trial
Citation
Tapiwa Mbengeranwa, IMPAACT P1078 TB APPRISE Study Team, Gaerolwe Masheto, Patrick Jean-Phillippe, Nahida Chakhtoura, Gerhard Theron, Adriana Weinberg, Haseena Cassim, Mpho S Raesi, Elsie Jean, Ashenafi S Cherkos, Deo Wabwire, Sylvia M LaCourse, Teacler Nematadzira, Daniel A Enquobahrie, Lynda Stranix-Chibanda, Barbra A Richardson, Anneke C Hesseling, Sarah Bradford, Linda Aurpibul, Grace Montepiedra, Amita Gupta, Blandina T Mmbaga, Grace John-Stewart. Effect of pregnancy versus postpartum maternal isoniazid preventive therapy on infant growth in HIV-exposed uninfected infants: a post-hoc analysis of the TB APPRISE trial. eClinicalMedicine. 2023. 58: 101912. PMID: 36969345Year
2023
Journal
eClinicalMedicine
Study
P1078
Progesterone and prolactin levels in pregnant women living with HIV who delivered preterm and low birthweight infants: A nested case-control study
Citation
Sean S. Brummel, Patricia DeMarrais, Rachel Chamanga, Maxensia Owor, Sufia Dadabhai, Joan T. Price, Taha Taha, Jeffrey Stringer, Mary Glenn Fowler, Benjamin H. Chi, Dorothy Sebikari. Progesterone and prolactin levels in pregnant women living with HIV who delivered preterm and low birthweight infants: A nested case-control study. PLoS One. 2023. 18: e0280730. PMID: 36689442Year
2023
Journal
PLoS One
Study
1077BF, 1077FF
The cascade of care for household contacts of people with drug-resistant TB
Citation
Gavin Churchyard, Amita Gupta, Anneke C Hesseling, Susan Swindells, Wilfred Gurupira, Bruno Martel, Lungile Mbata, Sandesh Patil, Cynthia Riviere, Mariecef Tonquin, David Dowdy, Hojoon Sohn, Isabella Gomes, Tushar Garg. The cascade of care for household contacts of people with drug-resistant TB. International Journal of Tuberculosis and Lung Disease. 2023. 27: 154-156. PMID: 36853100Year
2023
Journal
International Journal of Tuberculosis and Lung Disease
Study
IMPAACT 2003/ACTG 5300
Factors associated with prevalent Mycobacterium tuberculosis infection and disease among adolescents and adults exposed to rifampin-resistant tuberculosis in the household
Citation
Xingye Wu, Rosie Mngqbisa, Michael D Hughes, Rodrigo Otávio da Silva Escada, N Sarita Shah, Samuel Ouma, Sanjay Gaikwad, Barbara Heckman, Nishi Kumarasamy, Linda Naini, Erika Mitchell, Amita Gupta, Mey Leon, Susan Swindells, Pedro Gonzales, Gavin Churchyard, Sharlaa Badal-Faesen, ACTG A5300/IMPAACT 2003 PHOENIx Feasibility Study Team, Madeleine Lourens, Sandy Nerette, Justin Shenje, Petra de Koker, Supalert Nedsuwan, Soyeon Kim, Lerato Mohapi, Anneke C Hesseling, Unoda A Chakalisa. Factors associated with prevalent Mycobacterium tuberculosis infection and disease among adolescents and adults exposed to rifampin-resistant tuberculosis in the household. PLoS One. 2023. 18: e0283290. PMID: 36930628Year
2023
Journal
PLoS One
Study
IMPAACT 2003/ACTG 5300
Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial
Citation
Kevin Knowles, Roger Shapiro, Sikhulile Moyo, Blandina Theophil Mmbaga, Lynda Stranix-Chibanda, Faeezah Patel, Risa Hoffman, Jean van Wyk, Paul E Sax, James F Rooney, Jeffrey Stringer, Judith S Currier, Nahida Chakhtoura, Shahin Lockman, Patrick Jean-Philippe, IMPAACT 2010/VESTED Study Team and Investigators, Violet Korutaro, Lameck Chinula, Haseena Cassim, Lauren Ziemba, Lee Fairlie, Sean Brummel, Gaerolwe Masheto, Katie McCarthy, Ceejay Boyce, Anne Coletti, Lisa M Frenkel, Chelsea Krotje, K Rivet Amico, Benjamin Johnston, Lynette Purdue. Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet HIV. 2023. S2352-3018: 00061-9. PMID: 37167996Year
2023
Journal
Lancet HIV
Study
IMPAACT 2010
A Per-Protocol Analysis using Inverse Probability of Censoring Weights in a Randomized Trial of Initial PI versus NNRTI Regimens in Children
Citation
Dwight E. Yin, Stephen R. Cole, Christina Ludema, M. Alan Brookhart, Carol E. Golin, William C. Miller, Ross E. McKinney. A Per-Protocol Analysis using Inverse Probability of Censoring Weights in a Randomized Trial of Initial PI versus NNRTI Regimens in Children. American Journal Of Epidemiology. 2023. 192: 916-928. PMID: 36896583Year
2023
Journal
American Journal Of Epidemiology
Pharmacokinetics, Safety, and Tolerability of Dispersible and Immediate-Release Abacavir, Dolutegravir and Lamivudine Tablets in Children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation study
Citation
Haseena Cassim, Kevin Ryan, Jaime G. Deville, Hardik Chandasana, Ponego L. Ponatshego, Cynthia H. Brothers, Faeezah Patel, Ann M. Buchanan, Linda Aurpibul, Helena Rabie, Shaun L. Barnabas, Patricia M. Flynn, Iris Mustich, IMPAACT 2019 Study Team, Anne Coletti, Barbara Heckman, Kristina M. Brooks, Chelsea Krotje, Jennifer J. Kiser, Mark Lojacono, Lauren Ziemba, Dwight E. Yin, Shawn Ward, Ellen Townley, Yasha Rani, Jack Moye, Tim R. Cressey, Sai Majji, Gaerolwe R. Masheto, Edward P. Acosta. Pharmacokinetics, Safety, and Tolerability of Dispersible and Immediate-Release Abacavir, Dolutegravir and Lamivudine Tablets in Children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation study. Lancet HIV. 2023. 10: E506-E517. PMID: 37541705Year
2023
Journal
Lancet HIV
Study
IMPAACT 2019
Timing of maternal isoniazid preventive therapy on tuberculosis infection among infants exposed to HIV in low-income and middle-income settings: a secondary analysis of the TB APPRISE trial
Citation
IMPAACT P1078 TB APPRISE Study Team, Aisa Shayo, Tichaona Vhembo, Mercy Mutambanengwe, Gaerolwe Masheto, Mpho Raesi, Sarah Bradford, Amanda Golner, Diane Costello, Vandana Kulkarni, Amita Gupta, Enid Kabugho, Priya Singh, Patrick Jean–Phillippe, Lisa Aaron, Nahida Chakhtoura, Grace Montepiedra, Timothy R. Sterling, Tsungai Chipato, Gerhard Theron, Lynda Stranix-Chibanda, Adriana Weinberg, Vongai Chanaiwa. Timing of maternal isoniazid preventive therapy on tuberculosis infection among infants exposed to HIV in low-income and middle-income settings: a secondary analysis of the TB APPRISE trial. Lancet Child and Adolescent Health. 2023. 7: 708-717. PMID: 37634517Year
2023
Journal
Lancet Child and Adolescent Health
Study
P1078
Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026s
Citation
Tim R. Cressey, David E. Shapiro, Kira Bacon, Kevin Knowles, Kathleen George, Renee Browning, Nahida Chakhtoura, Kittipong Rungruengthanakit, Lubbe Wiesner, Marije Van Schalkwyk, Edmund V. Capparelli, Adrie Bekker, Alice M. Stek, Eric Decloedt, Mark Mirochnick, Jiajia Wang, Brookie M. Best, Gerhard B. Theron, IMPAACT P1026s Protocol Team, Mark F. Cotton, Ahizechukwu C. Eke. Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026s. Journal Antimicrobial Agents and Chemotherapy. 2023. 67: e0073723. PMID: 37882552Year
2023
Journal
Journal Antimicrobial Agents and Chemotherapy
Study
P1026S
Dolutegravir Plasma Protein Binding and Unbound Concentrations During Pregnancy and Postpartum
Citation
Jeremiah D. Momper, Mina Nikanjam, Brookie M. Best, Mark Mirochnick, Edmund V. Capparelli, Tim R. Cressey. Dolutegravir Plasma Protein Binding and Unbound Concentrations During Pregnancy and Postpartum. Journal of Acquired Immune Deficiency Syndromes. 2023. 94: 332-336. PMID: 37884053Year
2023
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1026S